http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Shaoheng Li,Ziji Bai,Feiyang Rong,Jiayin Huang,Lipan Zhou,Guodong Feng,Zhiguang Song 한국공업화학회 2023 Journal of Industrial and Engineering Chemistry Vol.124 No.-
Palladium-catalyzed coupling reactions have become effective tools for forming new carbon–carbonbonds. In this work, a novel fluorescence active benzotriazole-coumarin derivative, (E)-N’-((1H-benzo[d][1,2,3]triazol-6-yl)methylene)-7-(diethylamino)-2-ox o-2H-chromene-3-carbohydrazide (BTANC),was synthesized as ligand in Pd(II) cation coordination. It is shown that BTANC has a strong fluorescentemission at 483 nm and Pd(II) can effectively quench the fluorescence of BTANC and BTANC shows excellentsensitivity and selectivity towards Pd (II) ions. Otherwise, the BTANC-Pd(II) complex was also testedin the Sonogashira coupling reaction of phenylacetylene and aryl halides. The desired product wasobtained with high yield (up to 99%) under the optimized reaction conditions. More to that, Low fluorescenceemission was observed during the Pd-catalyzed reaction process and the fluorescent emission ofBTANC was recovered at the end of the Pd-catalyzed reaction because the oxidative addition of the arylhalide towards Pd (0) was shut down at the end of the Pd-catalyzed reaction. This fluorescence propertiesof BTANC indicates the feasibility of using fluorescence signal as a potential tool to monitor the completionof the Sonogashira coupling reaction.
Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis
Lei Cheng,Jianjun Chen,Qingling Fu,Shaoheng He,Huabin Li,Zheng Liu,Guolin Tan,Zezhang Tao,Dehui Wang,Weiping Wen,Rui Xu,Yu Xu,Qintai Yang,Chonghua Zhang,Gehua Zhang,Ruxin Zhang,Yuan Zhang,Bing Zhou,Do 대한천식알레르기학회 2018 Allergy, Asthma & Immunology Research Vol.10 No.4
Allergic rhinitis (AR) is a global health problem that causes major illnesses and disabilities worldwide. Epidemiologic studies have demonstrated that the prevalence of AR has increased progressively over the last few decades in more developed countries and currently affects up to 40% of the population worldwide. Likewise, a rising trend of AR has also been observed over the last 2-3 decades in developing countries including China, with the prevalence of AR varying widely in these countries. A survey of self-reported AR over a 6-year period in the general Chinese adult population reported that the standardized prevalence of adult AR increased from 11.1% in 2005 to 17.6% in 2011. An increasing number of original articles and imporclinical trials on the epidemiology, pathophysiologic mechanisms, diagnosis, management and comorbidities of AR in Chinese subjects have been published in international peer-reviewed journals over the past 2 decades, and substantially added to our understanding of this disease as a global problem. Although guidelines for the diagnosis and treatment of AR in Chinese subjects have also been published, they have not been translated into English and therefore not generally accessible for reference to non-Chinese speaking international medical communities. Moreover, methods for the diagnosis and treatment of AR in China have not been standardized entirely and some patients are still treated according to regional preferences. Thus, the present guidelines have been developed by the Chinese Society of Allergy to be accessible to both national and international medical communities involved in the management of AR patients. These guidelines have been prepared in line with existing international guidelines to provide evidence-based recommendations for the diagnosis and management of AR in China.